Last reviewed · How we verify

NCT04244305

Endurance Training in Patients Undergoing Lung Transplantation

Status unknown NA Last updated 29 January 2020
What this trial tests

NA trial testing Exercise Therapy in Lung Transplantation in 80 participants. Status unknown.

Timeline
1 May 2016
Primary endpoint
30 May 2019
1 May 2020

Quick facts

Lead sponsorUniversity Hospital A Coruña
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 May 2016
Primary completion30 May 2019
Estimated completion1 May 2020

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital A Coruña

Who can join

18 and older, any sex, with Lung Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lung Transplantation is usually the last option for patients with chronic respiratory conditions in the late stages of the disease. Pulmonary rehabilitation and, particularly, endurance training, is a cornerstone in the management of these patients both during the pre-operative as well as the post-operative period as it improves cardiopulmonary fitness, muscle mass, muscle strength, health-related quality of life and potentially, survival. However, very few studies have been published addressing which modality of training, intensity, frequency or duration of training provides the best possible results in these patients. Therefore, the objective of this study was to compare two training modalities (treadmill walking versus cycle-ergometry) on functional capacity, muscle strength and lung function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise Therapy

Trials testing the same drug.

Other recruiting trials for Lung Transplantation

Currently open trials in the same condition.

Other University Hospital A Coruña trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04244305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing